Ana Tsakova, managing director at Merck Bulgaria, emphasizes the duty of the industry to raise the bar of treatment quality in the country and shows the commitment of Merck in this regard to collaborate with both physicians and patients in key therapeutic areas such as oncology, fertility, multiple sclerosis, diabetes, and thyroid diseases.
Could you please introduce yourself and your professional career to our international audience?
"As in any pharmaceutical company, the right product portfolio is a key factor to successfully navigate in the market, but it needs to be supported by the right talented people."
